Clinical Trial

ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)

Study acronym: INTERPRET
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective observational study that will collect blood samples at 1-10 timepoints related to initiation of immunotherapy. The study may collect samples before the start of immunotherapy and/or at clinically significant timepoints during immunotherapy treatment.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-21; most recent amendment 2026-07-14.
Trial Details
NCT Number NCT06900296
Lead Sponsor Indiana University
Collaborators: Indiana Institute of Personalized Medicine
Conditions Cancer
Enrollment 100 participants
Start Date 2028-01
Primary Completion 2029-04 (estimated)
Study Completion 2029-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-15